Atlas Trials

First-line Antibiotic Therapy for Early-stage HP(+) Gastric Pure DLBCL

Clinical trial NCT02388581 · UNKNOWN

Trial details

NCT number
NCT02388581
Sponsor
National Health Research Institutes, Taiwan
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric Diffuse Large B-cell Lymphoma
Start date
2014-12-01
Primary completion
2017-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.